|
Name |
2,3-Dimethyl-2-cyclopenten-1-one
|
Molecular Formula | C7H10O | |
IUPAC Name* |
2,3-dimethylcyclopent-2-en-1-one
|
|
SMILES |
CC1=C(C(=O)CC1)C
|
|
InChI |
InChI=1S/C7H10O/c1-5-3-4-7(8)6(5)2/h3-4H2,1-2H3
|
|
InChIKey |
UZLQSPYGTUMKGS-UHFFFAOYSA-N
|
|
Synonyms |
2,3-Dimethyl-2-cyclopenten-1-one; 1121-05-7; 2,3-Dimethylcyclopent-2-en-1-one; 2-Cyclopenten-1-one, 2,3-dimethyl-; 2,3-DIMETHYL-2-CYCLOPENTENONE; Y6A4YU4DWN; 2,3-dimethylcyclopent-2-enone; dimethylcyclopentenone; 2-Cyclopenten-1-one,2,3-dimethyl-; UNII-Y6A4YU4DWN; SCHEMBL161507; 2,3-Dimethyl-cyclopent-2-enone; DTXSID80149901; ZINC2039884; 2,3-dimethyl-cyclopent-2-en-1-one; 2,3-Dimethylcyclopenta-2-en-1-one; AKOS015912514; 2,3-Dimethyl-2-cyclopenten-1-one #; Cyclopent-2-en-1-one, 2,3-dimethyl; 2,3-Dimethyl-2-cyclopenten-1-one, 99%; CS-0253128; EN300-62493; J-002707; Q63395351
|
|
CAS | 1121-05-7 | |
PubChem CID | 14270 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 110.15 | ALogp: | 0.8 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.467 |
Caco-2 Permeability: | -4.429 | MDCK Permeability: | 0.00002860 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.023 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 56.61% |
Volume Distribution (VD): | 0.767 | Fu: | 62.01% |
CYP1A2-inhibitor: | 0.653 | CYP1A2-substrate: | 0.833 |
CYP2C19-inhibitor: | 0.252 | CYP2C19-substrate: | 0.873 |
CYP2C9-inhibitor: | 0.035 | CYP2C9-substrate: | 0.661 |
CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.621 |
CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.305 |
Clearance (CL): | 9.626 | Half-life (T1/2): | 0.828 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.029 |
Drug-inuced Liver Injury (DILI): | 0.125 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.208 | Maximum Recommended Daily Dose: | 0.097 |
Skin Sensitization: | 0.279 | Carcinogencity: | 0.31 |
Eye Corrosion: | 0.931 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.194 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002343 | 0.500 | D0Z8AA | 0.222 | ||||
ENC001840 | 0.421 | D0N0OU | 0.205 | ||||
ENC001459 | 0.421 | D0Z8SF | 0.200 | ||||
ENC004598 | 0.362 | D00EEL | 0.190 | ||||
ENC005199 | 0.356 | D0H6VY | 0.188 | ||||
ENC005114 | 0.311 | D0K7LU | 0.186 | ||||
ENC005198 | 0.291 | D00IUG | 0.179 | ||||
ENC002195 | 0.269 | D0S5CH | 0.179 | ||||
ENC001280 | 0.265 | D00ETS | 0.175 | ||||
ENC005108 | 0.265 | D0Q4XQ | 0.175 |